Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Wolf speed -- Ignore unavailable to you. Want to Upgrade?

To: unclewest who wrote (4465)	12/5/2000 9:37:05 PM
From: Mephisto	Read Replies (1) \| Respond to of 10713

Greenberg Has It Wrong "I spoke with Cynthia Merrell, Cree's CFO, about this issue and she told me that Greenberg has it wrong. She says Microvision badly needs Cree's help on a blue laser product, and Cree incurred expenses by accelerating its research in this area. According to Merrell, Microvision's $3.1 million payment was basically a reimbursement to Cree for the additional expenses. In other words, operating income would have been the same without the Microvision arrangement, because Cree would not have incurred those expenses to begin with. Excerpt from: Addressing Cree Concerns Cree has been criticized for its R&D arrangements with other companies; some well-known shorts say those deals have artificially added to the bottom line. CFO Cynthia Merrell says that's not the case. " By Rex Moore (TMF Orangeblood) From: The Motely Fool fool.com